© 2026 Forbes Media LLC. All Rights Reserved.

Michael Saylor’s Strategy just bought $1.28 billion worth of Bitcoin, while Nasdaq is teaming up with Kraken for tokenized stock trading.

© 2026 Forbes Media LLC. All Rights Reserved.

Wall Street is drawing fresh lines across the large-cap biopharma landscape. Jefferies initiated coverage on Gilead Sciences Inc. (NASDAQ:GILD) with a Buy rating and a $180 price target, while ...

When enterprise commerce organizations lose market share, or their innovation velocity drops, there’s no shortage of suspects to blame: too few ideas from the team, a market that moves too fast, ...

Here's the full list of winners from the 2026 GLAAD Media Awards, which were presented on March 5 in L.A. Winners included ...

Find the top generative engine optimization tools for 2026 to track AI mentions, monitor brand performance, and grow your reach in AI-powered search engines.

At $24.50, what you're really getting with Catalyst Pharmaceuticals Inc. (CPRX, Financial) isn't growth. It's time. The company offers a free cash flow yield of about 7.5%. This is predicated on the ...

This walkthrough covers the ending of Resident Evil Requiem, including entering the Archives, reaching the Central Refinery, ...

Looking for alternatives to Profound AI? Discover top tools in 2026 to optimize and monitor your brand’s visibility across AI-driven search experiences.

Read the latest healthcare, biotech, and pharmaceutical stock news and analysis. Uncover the latest research and company analysis to empower your investments.

Chainlink secures $100B+ in assets yet LINK trades at $8.90 — down 83% from ATH. We break down an expert Chainlink price prediction from $13 to $195.